Litigation Details for Eli Lilly and Company v. Apotex, Inc. (E.D. Va. 2016)
✉ Email this page to a colleague
Eli Lilly and Company v. Apotex, Inc. (E.D. Va. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-11-29 |
| Court | District Court, E.D. Virginia | Date Terminated | 2017-03-13 |
| Cause | 35:271 Patent Infringement | Assigned To | Anthony John Trenga |
| Jury Demand | None | Referred To | Michael S. Nachmanoff |
| Patents | 6,943,166 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Eli Lilly and Company v. Apotex, Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Eli Lilly and Company v. Apotex, Inc. (E.D. Va. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-11-29 | 1 | e)(2) for infringement of U.S. Patent No. 6,943,166 (“the ’166 patent”). … 1. This is an action for patent infringement arising under the patent laws of the United States, … PATENT-IN-SUIT 30. On September 13, 2005, the U.S. Patent and Trademark Office…copy of the ’166 patent is attached hereto as Exhibit A. The claims of the ’166 patent are valid and enforceable…and 20 mg dosage strengths. The ’166 patent is one of the patents listed in the FDA publication entitled | External link to document | |
| 2017-03-13 | 11 | is enjoined from infringing U.S. Patent No. 6,943,166 ("the '166 patent"), on its own part or through any…2016 13 March 2017 1:17-cv-00015 830 Patent None District Court, E.D. Virginia | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
